1. Scrip
  2. >>Partnered Content

Navigating CAR T Delivery In Autoimmune Indications: Impact & Opportunity

Indications: Impact & Opportunity
ICON Biotech

CAR T-cell therapy landscape has undergone significant growth, with over 1,000 therapies now in development worldwide. Beyond cancer, complex autoimmune diseases have become a key focus area, with the hope of addressing a high unmet need in life sciences.

Uncover the essential strategies for CAR T-cell therapy success in the treatment of complex autoimmune diseases, as the article explores:

  • Promising results from a study on CAR T-cell therapy
  • Importance of site design, specialist expertise and communication
  • Difficulties around manufacturing and scalability
  • Vital role of industry partnerships, geographical expansion and community organizations

Download the article: Navigating CAR T Delivery In Autoimmune Indications: Impact & Opportunity

More from Partnered Content

Sponsored by:

Japan’s Strengths As A Clinical Study Location And Why Selecting The Right Partner Is Crucial

Learn about the critical role the right CRO plays in successfully navigating the significant drug development opportunities in Japan.

Sponsored by:

Oncology R&D trends at a glance

Access key stats from biotechs on the latest trends impacting oncology R&D, including therapeutic pipelines and clinical trial challenges, AI/ML, and a future outlook on innovation.

Sponsored by:

Infographic: Advancing Drug Development in Oncology

Gain exclusive insights into the biggest challenges biotechs face in oncology and uncover the latest opportunities to accelerate drug development.

Sponsored by:

Roundtable Report: Keeping Pace with CGT Innovation

CGTs are among the fastest-growing areas in therapeutics - explore the key strategies driving long-term commercial success across the entire product lifecycle.

More from Scrip

Sponsored by:

Making medicines more affordable to the NHS

Delve into the challenges facing the NHS, from rising medicine costs to supply shortages, and how generics and branded generics can provide solutions for a more sustainable healthcare system

Sponsored by:

Japan’s Strengths As A Clinical Study Location And Why Selecting The Right Partner Is Crucial

Learn about the critical role the right CRO plays in successfully navigating the significant drug development opportunities in Japan.

Sponsored by:

Oncology R&D trends at a glance

Access key stats from biotechs on the latest trends impacting oncology R&D, including therapeutic pipelines and clinical trial challenges, AI/ML, and a future outlook on innovation.

Sponsored by:

Infographic: Advancing Drug Development in Oncology

Gain exclusive insights into the biggest challenges biotechs face in oncology and uncover the latest opportunities to accelerate drug development.